Address
Oakwood Medical Investors
10411 Clayton Road
Suite 302
St Louis, MO 63131
United States
Website
Recent investment activity
KANDO id: 30962
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Oakwood Medical Investors V | 2008 | USD | 125,000,000 | |
| Oakwood Medical Investors IV | 2004 | USD | 43,000,000 | |
| Oakwood Medical Investors III | 2001 | USD | 24,000,000 | |
| Oakwood Investors I | 1999 | USD | 4,000,000 | |
| Oakwood Medical Investors II | 1999 | USD | 6,000,000 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 21 of 21| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Argos Therapeutics Inc | Series B | ||||
|
|
CryoCor Inc | N/A | ||||
|
|
Ekos Corp | Series C | ||||
|
|
EndoStim Inc | Medical device company developing devices to treat gastrointestinal and urological neuro-muscular disorders. | N/A | |||
|
|
Inhibitex Inc | N/A | ||||
|
|
Insulet Corp | N/A | ||||
|
|
MedVantx Inc | N/A | ||||
|
|
Mitralign Inc | Percutaneous mitral valve repair system. | Series C | |||
|
|
Stereotaxis Inc | Medical device company engaged in the field of image guided interventional surgery | N/A | |||
|
|
TransMolecular Inc | TransMolecular is a biotechnology company. | N/A | |||
|
|
ViaCyte Inc | N/A | ||||
|
|
Achillion Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. | N/A Initial investment | |||
|
|
Adiana Inc | Series D | ||||
|
|
Aptus Endosystems Inc | N/A | ||||
|
|
AtheroGenics Inc | N/A Initial investment | ||||
|
|
EndoGastric Solutions Inc | Series F | ||||
|
|
EndoGastric Solutions Inc | Series E | ||||
|
|
EndoGastric Solutions Inc | N/A | ||||
|
|
LipoScience Inc | Diagnostic company developing clinical applications of nuclear magnetic resonance (NMR) spectroscopy. | N/A | |||
|
|
Sadra Medical Inc | Series C Follow-on investment | ||||
|
|
Sadra Medical Inc | Series B Initial investment |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Daniel A Burkhardt | [email protected] | |||
| Jason A Darrah | Director
Research |
[email protected] | ||
| Steven D Girouard | [email protected] | |||
| Raul E Perez | [email protected] |